selected publications
-
academic article
- Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.. JAMA oncology. 3:1327-1334. 2017
- Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. 2016
- Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.. JAMA oncology. :-. 2016
- Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. :-. 2015
- Usability Testing of an HPV Information Website for Parents and Adolescents.. Online journal of communication and media technologies. 5:184-203. 2015
- The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status.. The American journal of surgical pathology. 39:729-736. 2015
- Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs.. The Journal of School Health. 85:289-298. 2015
- A population-based evaluation of cervical screening in the United States: 2008-2011.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23:765-773. 2014
- A population-based evaluation of cervical screening in the United States: 2008-2011.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23:765-773. 2014
- Beta-test Results for an HPV Information Web site: GoHealthyGirls.org - Increasing HPV Vaccine Uptake in the United States.. Journal of consumer health on the Internet. 18:226-237. 2014
- A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.. International journal of cancer. Journal international du cancer. 132:198-207. 2013
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.. The Lancet. Oncology. 13:100-110. 2012
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.. The Lancet. Oncology. 13:89-99. 2012
- Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.. International journal of cancer. Journal international du cancer. 126:2969-2983. 2010
- Impact of improved classification on the association of human papillomavirus with cervical precancer.. American journal of epidemiology. 171:155-163. 2010
- Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.. Journal of the National Cancer Institute. 101:475-487. 2009
- The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.. The Journal of infectious diseases. 199:936-944. 2009
- HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.. Qualitative health research. 18:584-596. 2008
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.. Lancet. 369:2161-2170. 2007
-
document